Literature DB >> 10422876

Urocortin in human placenta and maternal plasma.

F Watanabe1, Y Oki, M Ozawa, M Masuzawa, M Iwabuchi, T Yoshimi, T Nishiguchi, K Iino, H Sasano.   

Abstract

Plasma immunoreactive (IR-) urocortin (Ucn) and corticotropin-releasing factor (CRF) levels in pregnant women were measured by their specific radioimmunoassays after extraction. Although plasma IR-CRF levels were increased in pregnant women as compared to men and non-pregnant women, there was no difference of plasma IR-Ucn levels among groups. Ucn mRNA was detected in cytotrophoblasts and syncytiotrophoblasts by in situ hybridization. A reverse-phase high-performance liquid chromatography (HPLC) showed the major peak of IR-Ucn in placenta and plasma that had similar chromatographic mobility to synthetic Ucn1-40. These data suggest that Ucn is produced and processed into the same form of synthetic Ucn in placenta, but not secreted into maternal blood.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10422876     DOI: 10.1016/s0196-9781(98)00175-2

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

Review 1.  Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family.

Authors:  Pasquale Florio; Filiberto M Severi; Pasquapina Ciarmela; Giovina Fiore; Giulia Calonaci; Angelica Merola; Claudio De Felice; Marco Palumbo; Felice Petraglia
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Mechanisms of the protective effects of urocortin on coronary endothelial function during ischemia-reperfusion in rat isolated hearts.

Authors:  Angel Luis García-Villalón; Yesika María Amezquita; Luis Monge; Nuria Fernández; Belén Climent; Ana Sánchez; Godofredo Diéguez
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  Relaxation by urocortin of human saphenous veins.

Authors:  Elena Sanz; Luis Monge; Nuria Fernández; María Angeles Martínez; Juan B Martínez-León; Godofredo Diéguez; Angel Luis García-Villalón
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

4.  CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators.

Authors:  Katherine E Wiley; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739

Review 5.  Urocortin and the brain.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-11-07       Impact factor: 11.685

6.  Cardiac expression of urocortin (Ucn) in diseased heart; preliminary results on possible involvement of Ucn in pathophysiology of cardiac diseases.

Authors:  Keiichi Ikeda; Katsuyoshi Tojo; Goro Tokudome; Makoto Ohta; Ken-ichi Sugimoto; Tadashi Tamura; Naoko Tajima; Seibu Mochizuki; Makio Kawakami; Tatsuo Hosoya
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

7.  Distribution of urocortins and corticotropin-releasing factor receptors in the cardiovascular system.

Authors:  Kazuhiro Takahashi
Journal:  Int J Endocrinol       Date:  2012-05-17       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.